1例视网膜母细胞瘤术后化疗伴病理性疼痛患儿的药学监护  

Pharmaceutical Care of a Case of Child with Retinoblastoma Postoperative Chemotherapy with Pathological Pain

作　　者：胡志强[1] 郑晓俊[1] 

机构地区：[1]山西医科大学第一医院药学部,太原030001

出　　处：《中国药房》2015年第17期2432-2435,共4页China Pharmacy

摘　　要：目的:探讨临床药师在视网膜母细胞瘤(RB)术后化疗伴病理性疼痛患儿治疗中的作用。方法:临床药师通过参与临床查房,关注化疗方案的合理性及安全性,确定患儿止痛治疗方案以及抗感染治疗。结果:通过实施个体化治疗方案,同时对不良反应进行预防与监护,使患儿顺利度过了化疗期。结论:临床药师通过全程参与患儿的治疗,及时提供有效的建议,有益于药物合理应用和减轻患儿的痛苦。OBJECTIVE： To investigate the role of clinical pharmacists in the treatment of child with retinoblastoma （RB） postoperative chemotherapy with pathological pain. METHODS： Through participating in clinical rounds, clinical pharmacists concerned about the rationality and safety of chemotherapy regimens, gave anti-infection treatment. RESULTS： The child got through the chemotherapy stage by individualizing treatment regimens and preventing and caring the adverse reactions. CONCLUSIONS： Clinical pharmacists participate in the entire treatment process of child, and provide timely and effective recommendations to promote rational drug use and alleviate the suffering of child.

关 键 词：药学监护 视网膜母细胞瘤 术后化疗 

分 类 号：R971.2[医药卫生—药品]